Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PURPOSE: The objective of this study was to determine the prevalence of colonization, serotype distribution, and antimicrobial susceptibility profile of Streptococcus pneumoniae (Pneumococcus) isolated from human immunodeficiency virus (HIV)-infected children before and after single-dose of 13-valent pneumococcal conjugate vaccine (PCV13) vaccination. MATERIALS AND METHODS: We conducted a prospective cohort study among HIV-infected children above six years of age in Jakarta, Indonesia. Nasopharyngeal swabs were collected from 50 children before vaccination, 12 months, and 18 months after PCV13 vaccination. The swabs were evaluated by bacterial culture, and serotyping were performed using sequential multiplex polymerase chain reactions and Quellung reactions. Antimicrobial susceptibility profiles were determined using the disk diffusion method. RESULTS: We found Streptococcus pneumoniae colonized 46% (23/50) of total children enrolled before vaccination, which decreased to 19% (n=9/47) at 12 months post-vaccination and 29% (14/48) at 18 months post-vaccination. There was no significant difference in the prevalence of pneumococcal colonization between vaccinated and unvaccinated HIV-infected children (p>0.05). There was a significant decrease in pneumococcal colonization between the baseline, 12 months, and 18 months after vaccination among vaccinated children (p<0.05). Vaccine-type (VT) serotypes (6B, 23F, and 19A) were more prevalent than non-vaccine serotypes before vaccination. Non-vaccine type (NVT) serotypes (6C, 15C) were more prevalent at 12 months post-vaccination. VT serotypes were found at 18 months post-vaccination in vaccinated children. There was a high prevalence of antimicrobial resistance to S. pneumoniae isolates to oxacillin, tetracycline, and sulfamethoxazole-trimethoprim before and after vaccination. CONCLUSION: There was a decrease in pneumococcal carriage after PCV vaccination in HIV-infected children, accompanied by changes in serotype distribution from VT serotypes to NVT serotypes.

Original publication

DOI

10.7774/cevr.2025.14.e19

Type

Journal article

Journal

Clin Exp Vaccine Res

Publication Date

04/2025

Volume

14

Pages

127 - 137

Keywords

Children, HIV, Indonesia, Streptococcus pneumoniae, Vaccination